Naeja Pharmaceutical Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

Forward Citations = 41

Loading Chart...

13 inventors (with patents filed for the assignee):

Rong Ling (2 out of 14 patents)

Rajeshwar Singh (2 out of 38 patents)

Samarendra N Maiti (2 out of 22 patents)

4. Jehangir Khan (2 out of 9 patents)

5. Nian Zhou (2 out of 2 patents)

6. Ronald G Micetich (2 out of 42 patents)

7. Dai Q Nguyen (2 out of 14 patents)

8. Mark Whittaker (1 out of 17 patents)

9. Deqi Guo (1 out of 21 patents)

10. Qizhu Ding (1 out of 3 patents)

11. Andhe V N Reddy (1 out of 1 patent)

12. Jadwiga Kaleta (1 out of 4 patents)

13. George Thomas (1 out of 5 patents)

4 patents: Sort by Forward Citations

1. 8877743 - Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors (2014-11-04),

2. 8796257 - Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors (2014-08-05),

3. 6635621 - Cysteine protease inhibitors (2003-10-21),

4. 6232305 - Substituted amino bicyclic-&bgr;-lactam penam and cepham derivatives as cysteine protease inhibitors (2001-05-15),

Company Overview

Naeja Pharmaceutical Inc. is a leading biopharmaceutical company focused on developing innovative therapies for various diseases. With a strong pipeline of cutting-edge drugs, we are committed to improving the lives of patients worldwide. Our team of dedicated scientists and researchers work tirelessly to bring new treatment options to market, driving advancements in healthcare and making a positive impact on the global community.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#71 in Edmonton

#3,470 in Canada

Edmonton, Canada